These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 29206319)
1. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319 [TBL] [Abstract][Full Text] [Related]
2. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective. Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383 [TBL] [Abstract][Full Text] [Related]
3. Screening for proteinuria in US adults: a cost-effectiveness analysis. Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273 [TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease. Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME; BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of primary screening for CKD: a systematic review. Komenda P; Ferguson TW; Macdonald K; Rigatto C; Koolage C; Sood MM; Tangri N Am J Kidney Dis; 2014 May; 63(5):789-97. PubMed ID: 24529536 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States. Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Critselis E; Vlahou A; Stel VS; Morton RL Nephrol Dial Transplant; 2018 Mar; 33(3):441-449. PubMed ID: 29106632 [TBL] [Abstract][Full Text] [Related]
8. Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease. Wang H; Yang L; Wang F; Zhang L BMC Nephrol; 2017 Apr; 18(1):135. PubMed ID: 28420333 [TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of an abdominal aortic aneurysm screening program in Italy. Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Kondo M; Yamagata K; Hoshi SL; Saito C; Asahi K; Moriyama T; Tsuruya K; Yoshida H; Iseki K; Watanabe T Clin Exp Nephrol; 2012 Apr; 16(2):279-91. PubMed ID: 22167460 [TBL] [Abstract][Full Text] [Related]
11. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease. Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B; Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579 [TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882 [TBL] [Abstract][Full Text] [Related]
13. Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients. Zoccali C; Abd ElHafeez S; Dounousi E; Anastasi R; Tripepi G; Mallamaci F Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):85-90. PubMed ID: 27442374 [TBL] [Abstract][Full Text] [Related]
14. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812 [TBL] [Abstract][Full Text] [Related]
15. Screening for chronic kidney diseases among an adult population. Fatema K; Abedin Z; Mansur A; Rahman F; Khatun T; Sumi N; Kobura K; Akter S; Ali L Saudi J Kidney Dis Transpl; 2013 May; 24(3):534-41. PubMed ID: 23640626 [TBL] [Abstract][Full Text] [Related]
16. Comparison of urine dipstick and albumin:creatinine ratio for chronic kidney disease screening: A population-based study. Park JI; Baek H; Kim BR; Jung HH PLoS One; 2017; 12(2):e0171106. PubMed ID: 28151999 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience. Chen PM; Wada T; Chiang CK Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442 [TBL] [Abstract][Full Text] [Related]
18. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis. Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731 [TBL] [Abstract][Full Text] [Related]
19. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136 [TBL] [Abstract][Full Text] [Related]
20. Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea. Kim SW; Kang GW J Korean Med Sci; 2015 Dec; 30(12):1723-32. PubMed ID: 26713046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]